Arkolith/Insider Trading/TMCI/Form 4

Treace John T.

Chief Executive Officer, Director, 10% OwnerTREACE MEDICAL CONCEPTS, INC. (TMCI) · full profile →Form 4 · filed Jan 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 22, 2026Tax withholding(F)14K—$06.8M
Jan 22, 2026Grant(A)250K—$07.0M

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-021449) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML